Figures index

From

Complete Disappearance of Numerous Hepatic and Adrenal Metastases after One Dose of Pembrolizumab in a Patient with Metastatic Malignant Melanoma

Muhammad Zubair Afzal, Keisuke Shirai

American Journal of Medical Case Reports. 2019, 7(2), 22-23 doi:10.12691/ajmcr-7-2-2
  • Figure 1. A= Pre-treatment PET/CT showing metastatic lesions in liver and adrenal gland, B= Disappearance of metastatic lesions after one cycle of pembrolizumab